AVID BIOSERVICES INC. - COMMON STOCK

Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

06 3 2024 23:58:48 提供 Nasdaq GlobeNewswire

Avid Bioservices Announces Proposed Private Placement of Convertible Notes

06 3 2024 16:32:07 提供 Nasdaq GlobeNewswire

Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024

06 3 2024 16:31:28 提供 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023

07 12 2023 16:05:38 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023

30 11 2023 16:05:57 提供 Nasdaq GlobeNewswire

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

08 11 2023 08:05:03 提供 Nasdaq GlobeNewswire

Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility

17 10 2023 08:05:09 提供 Nasdaq GlobeNewswire

Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference

26 9 2023 16:05:51 提供 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023

07 9 2023 16:05:25 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023

31 8 2023 16:05:10 提供 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023

21 6 2023 16:07:37 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023

14 6 2023 16:05:54 提供 Nasdaq GlobeNewswire

Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference

10 5 2023 16:05:31 提供 Nasdaq GlobeNewswire

Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers

04 4 2023 08:05:38 提供 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments

13 3 2023 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023

06 3 2023 16:05:56 提供 Nasdaq GlobeNewswire

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments

06 12 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022

29 11 2022 16:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices Appoints Oksana Lukash as Vice President, People

16 11 2022 08:05:00 提供 Nasdaq GlobeNewswire

Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference

02 11 2022 16:05:01 提供 Nasdaq GlobeNewswire